What Bicitra Treats: Main Uses and Benefits

Bicitra (Citric Acid and Sodium Citrate) is a prescription oral solution that is applied in addressing conditions marked by increased physiological stress related to chronic internal imbalances. It is generally used to provide supportive symptom management in areas involving persistent systemic issues and recurrent complications.

This product is used in the management of chronic acidosis and to support the maintenance of alkaline urine.

This medication is commonly used to help with conditions characterized by periods of heightened symptoms related to: Chronic Metabolic Acidosis, Renal Tubular Acidosis, and Uric Acid Kidney Stones (for prevention).

“It supports the body during difficult episodes by may help address the symptom load associated with chronic acid buildup.”

Managing Systemic Imbalances and Recurrent Complications

Bicitra is applied across domains where additional symptomatic support is needed to manage the systemic imbalance of acid that occurs in conditions like Chronic Metabolic Acidosis. The therapeutic benefit is supporting the systemic acid-base balance, which assists with maintaining functional stability and supports day-to-day comfort. For the urinary system, Bicitra is commonly used for recurrent or episodic manifestations, specifically by supporting the therapeutic context of uric acid kidney stone formation. This support contributes to easing the overall symptom load by assisting with maintaining functional stability, which may help patients cope with symptom fluctuations related to stone formation.

Quick Fact: Support for Symptoms related to Systemic Imbalance

Regulatory References

1. Sodium Citrate and Citric Acid Oral Solution Indications

Who can and cannot use Bicitra?

The population eligibility for Bicitra (Citric Acid and Sodium Citrate Oral Solution) is strictly defined by regulatory documents, primarily based on the patient's renal function and electrolyte balance, as the drug contains a significant sodium load and requires proper excretion.

Populations for Whom Use is Contraindicated

Bicitra must not be used in patients diagnosed with Severe Renal Impairment, Anuria, Oliguria, or Azotemia (severe kidney/urinary dysfunction). Use is also prohibited in patients with pre-existing conditions that could be worsened by its components, including Hyperkalemia, Untreated Addison's Disease, Severe Myocardial Damage, and those strictly on a Sodium-Restricted Diet.

Age-Related and Conditional Use

The medicine is established for use in adults and children two years of age and older. Use in children under two years is not established, and dosage must be determined by a physician. Caution is advised for patients with Impaired Renal Function (when not severe), Cardiac Failure, Hypertension, or Toxemia of Pregnancy, as its sodium content may pose a risk. Use during general pregnancy or lactation has not been established in adequate studies.

Bicitra (sodium citrate and citric acid solution) acts as a systemic alkalinizing agent, and its primary drug interactions stem from its ability to raise the pH of both the stomach and the urine. These changes in pH can significantly alter the absorption and elimination of various other medications.

Interactions Affecting Absorption (Gastric pH Change)

Bicitra increases gastric pH, which can decrease the absorption and effectiveness of several orally administered drugs that require an acidic environment. These include certain antifungals (e.g., itraconazole, ketoconazole), some antiretrovirals (e.g., atazanavir), and medications like dasatinib. Conversely, this pH increase may elevate the levels or effects of drugs such as digoxin and certain calcium channel blockers (e.g., nimodipine).

Interaction Restrictions and Timing

Aluminum-containing antacids should not be taken with Bicitra because the resulting increased absorption of aluminum can lead to elevated serum aluminum concentrations. Additionally, Bicitra may decrease the absorption of tetracyclines and fluoroquinolones by chelation; if use is necessary, separate administration by at least two hours.

Interactions Affecting Elimination (Urine pH Change)

By alkalinizing the urine, Bicitra can decrease the renal excretion of certain basic drugs, such as amphetamines and quinidine. This decrease in elimination can lead to increased serum levels of the interacting medicine, potentially resulting in enhanced effects or toxicity.

How Bicitra Works: The Pharmacodynamic Mechanism

Bicitra is a systemic alkalizing agent that exerts its action via metabolic conversion and chemical buffering. The mechanism is initiated by the Citrate ion, which acts as a metabolic precursor. Citrate is absorbed into the systemic circulation and transported primarily to the liver, where it enters the Citric Acid Cycle (Krebs cycle) and is oxidized to generate Bicarbonate ( HCO3^-).

The newly formed Bicarbonate is released into the blood plasma, directly increasing the overall capacity of the Systemic Bicarbonate Buffer System. Bicarbonate chemically neutralizes excess Hydrogen Ions (H^+) circulating in the blood, leading to an elevation of the systemic pH. This chemical interaction modulates acid-base homeostasis.

The systemic pH modulation creates a secondary physiological effect in the kidneys. The kidneys filter the elevated Bicarbonate load, and the excess is excreted, causing the urine to become less acidic. This process results in Urinary Alkalinization, the final physiological consequence of the drug's systemic mechanism. The entire alkalizing process is dependent on unimpaired hepatic metabolism to complete the conversion of Citrate.

How to Use Bicitra (Citric Acid and Sodium Citrate)

Bicitra is used as an Oral Solution only, following a specific, structured administration protocol. The medication is typically prescribed as a long-term, chronic therapy to maintain continuous systemic alkalization.

---

Official Dosing and Administration Protocol

The dosage is not fixed but is highly individualized and determined by the prescribing practitioner based on a patient’s specific needs, clinical state, and continuous monitoring. The goal is often to adjust the dose volume to maintain a specific urinary pH or serum bicarbonate level.

Parameter	Administration Guideline
Route of Administration	Oral only, as a liquid solution.
Standard Dosing	The typical dose ranges from 10 mL to 30 mL (or 10 to 30 mEq of HCO3 equivalent) per dose for adults.
Frequency and Timing	The standard schedule is four times daily (Q.I.D.), taken consistently after meals and once at bedtime.
Preparation Requirement	The prescribed dose must be diluted in one to three ounces of water or juice immediately before ingestion to improve taste and enhance tolerability.
Dosing Measurement	A calibrated measuring device is required to ensure the precise mL volume prescribed by the doctor is taken.

---

Procedural Context

Due to the solution's acidic component, the official usage protocol includes rinsing the mouth thoroughly with plain water immediately after each dose is taken; this step is a standard procedural condition to mitigate potential effects on the teeth. The established Q.I.D. frequency, coupled with administration after meals, structures the entire use protocol, ensuring a steady delivery of the alkalizing agent throughout the day and evening. Pediatric dosing, when required, is typically determined based on the child's weight and clinical indicators.

Research Evidence Overview

This summary focuses strictly on the official research evidence for Bicitra (Citric Acid and Sodium Citrate), outlining the types of clinical studies and scientific findings that regulatory and intergovernmental bodies rely on. This information is derived from randomized controlled trials, systematic reviews, and official monographs, and does not provide clinical guidance or treatment recommendations.

---

Evidence for Managing Chronic Acidosis

Research has been conducted using this agent in conditions like Chronic Metabolic Acidosis and Renal Tubular Acidosis (RTA). The available evidence, which includes short-term Randomized Controlled Trials (RCTs) and longer-term observational cohorts, included studies that measured key biochemical markers. Studies explored the agent's effects in adults with non-dialysis dependent Chronic Kidney Disease (CKD) and in pediatric patients with RTA.

Research describes patterns observed in studies where serum bicarbonate levels were measured after the administration of the agent—a key marker measured in studies on acidosis. This research contributes to understanding how acid levels evolved in the observed populations. However, findings related to the long-term impact on slowing the progression of kidney disease were sometimes based on studies that grouped different alkali salts together, which contributes to the difficulty of attributing specific long-term functional effects. Furthermore, many older RTA studies had modest sample sizes, and follow-up durations were limited in some trials, meaning data on long-term functional outcomes remain uncertain.

---

Evidence for Preventing and Treating Kidney Stones

These studies included the measurement of key biomarkers in the urine, such as Urinary pH and Urinary Citrate excretion. Findings describe patterns observed in these studies where biomarkers showed measured changes after administration. Evidence regarding the study of uric acid stone management was associated with the changes in urinary pH observed in studies. However, comparative evidence for the prevention of calcium-containing stones is often grouped with findings from other similar citrate salts, meaning specific findings for this formulation remain uncertain.

Key Studies & References

1. Label: SODIUM CITRATE AND CITRIC ACID solution - DailyMed
2. Oral Dissolution Therapy of Uric Acid Stones: A Systematic Review

Common questions about Bicitra (FAQ)

---

Q: Why is Bicitra prescribed for kidney issues?

Official product information states that Bicitra is prescribed to address chronic metabolic acidosis, which often occurs alongside certain kidney issues like renal tubular disorders. The medication works by making the urine less acidic. This alkalinizing process is described in studies as useful in the management and prevention of specific types of kidney stones.

Q: Is Bicitra considered a safe medication for most people?

For individuals with normal kidney function, the official safety profile indicates that Bicitra is generally well tolerated when the product is taken according to the prescribing protocol. The decision to prescribe the medication is based on a doctor's assessment that the potential therapeutic benefits outweigh the possible risks for that patient.

Q: Is Bicitra safe for children to use?

The medication is established for use in children who are two years of age or older. For pediatric use, the official documents emphasize that dosing is highly individualized and is determined and supervised by a doctor.

Q: How long do most people have to take Bicitra?

According to the official product documents, Bicitra is typically prescribed as a long-term, chronic therapy. The purpose is to maintain continuous systemic alkalization and keep the urinary pH in a desired alkaline range over an extended period.

Q: Can Bicitra be taken during pregnancy?

Regulatory information notes that use during pregnancy should only occur when the medical need is clearly established. Caution is specifically noted because the medication may worsen high blood pressure conditions, such as toxemia of pregnancy.

Q: Is Bicitra safe for breastfeeding mothers?

Regulatory documents state that adequate studies have not been conducted to determine infant risk during breastfeeding. It is currently unknown if the active ingredients in the drug pass into breast milk.

Q: Are there any known issues with taking Bicitra long-term?

Long-term use generally requires official monitoring, particularly in patients with existing kidney issues. This monitoring often involves periodic blood work to check electrolyte levels, necessary to mitigate the risks of serious complications like metabolic alkalosis and high sodium levels (hypernatremia).

Q: What are the signs that Bicitra is working as intended?

The efficacy is typically assessed by monitoring clinical indicators. This usually involves checking blood work (specifically serum bicarbonate levels) and testing the pH of the urine to confirm that the environment is becoming less acidic as intended.

Q: How quickly does Bicitra start working?

The medication is designed to be absorbed quickly into the system. Official pharmacological information indicates that the peak concentration of the active component in the blood typically occurs approximately two hours after an oral dose is taken.

Q: What's the difference between Bicitra and other citrate medications?

Bicitra is formulated as a combination of sodium citrate and citric acid. This is a key difference from other similar medications, such as those that use potassium citrate, as the sodium or potassium component may be important depending on a patient's underlying health conditions.

Q: Is it normal to feel bloated when taking Bicitra?

The official safety information frequently lists general gastrointestinal discomfort as a common adverse reaction. Other digestive issues, such as diarrhea, nausea, and stomach pain, are also commonly reported.

Q: Does Bicitra affect blood pressure?

The medication contains sodium, and the official information advises caution for individuals with pre-existing conditions such as hypertension (high blood pressure) or swelling. The medication has the potential to affect overall fluid and electrolyte balance in the body.

Q: Are there any long-term effects of taking Bicitra?

The medication is generally intended for long-term use. Official guidelines indicate that periodic checks of serum electrolytes (blood work) are required to monitor for and mitigate potential long-term effects, such as changes in the body's acid-base balance.

Q: Does Bicitra interact with common pain relievers like Ibuprofen?

Official drug product information does not list a major interaction with the common pain reliever Ibuprofen. However, because the medication changes the pH of the urine, its effect on the elimination of other medicines can vary, and it is recommended to review all drug use with a healthcare provider.

Q: How does Bicitra help prevent kidney stones?

The medicine is used to prevent the formation of certain types of kidney stones, such as uric acid and cystine stones. It achieves this by making the urine more alkaline, which helps to dissolve and prevent the crystallization of stone-forming materials.

Q: Is Bicitra a sugar-free medication?

Most official formulations of Bicitra are prepared using a sugar-free base. However, the inactive ingredients may vary by brand, and patients with diabetes are advised to confirm the specific content of sugar or sugar-substitutes with their pharmacy.

Q: Can taking Bicitra cause dizziness or lightheadedness?

Lightheadedness is not listed as a common adverse reaction. However, official safety information indicates that symptoms such as lightheadedness or severe dizziness may be signs of a serious change in the body’s chemistry, like systemic alkalosis, and should be promptly reported to a healthcare provider.

Q: Does Bicitra have any known side effects on mood or sleep?

Official safety information lists certain mental or mood changes as potential serious side effects. These changes may include confusion or restlessness and should be promptly reported to a healthcare provider.

Q: Has Bicitra been studied in older adults?

The official regulatory documents state that there is no specific information available regarding the relationship of age to the effects of this combination product in geriatric (older adult) patients.

Q: Why do doctors often prescribe Bicitra before certain procedures?

In addition to its chronic systemic use, the product is officially used for quickly buffering and neutralizing stomach acid. For this specific purpose, it may be prescribed before certain procedures, such as the induction of anesthesia.

Q: Can Bicitra make me feel thirsty?

While not a common side effect, official safety information indicates that increased thirst can be a sign of high sodium levels (hypernatremia). This is listed as a potential serious adverse effect and should be promptly reported to a healthcare provider.

Q: Is Bicitra safe for people with liver disease?

Official cautions exist for individuals with hepatic impairment (liver disease). Regulatory documents note that the conversion of citrate into bicarbonate—the process required for the drug's action—occurs in the liver and may be impaired if the liver is not functioning properly.

Q: Is Bicitra a diuretic (water pill)?

No, Bicitra is classified as a Systemic Alkalizer and a Urinary Alkalinizer. It works to change the pH of the body and urine, which is different from how a diuretic (water pill) acts.

Q: Does Bicitra contain any allergens I should know about?

Official documentation advises patients to report all known allergies to foods, dyes, or preservatives. The inactive ingredients, which may vary by brand, often include substances such as sodium benzoate, sorbitol, and propylene glycol.

Q: Can Bicitra be used by people with diabetes?

Caution is officially advised for people with diabetes. This is because some liquid forms of the product may contain sugar or sugar substitutes, and the ingredients is advised to be confirmed with a healthcare provider.

Q: Is Bicitra used for gout?

Yes, Bicitra is officially indicated to help prevent or manage gout. The medication works by lowering the amount of uric acid in the urine, a process that helps prevent the formation of uric acid stones associated with gout.

Q: Is it true that Bicitra can sometimes cause muscle twitching?

The official safety information lists muscle spasms, tremors, or twitching muscles as potential signs of a serious change in the body's electrolyte balance. For instance, this can be a symptom of high sodium levels or systemic alkalosis, and should be promptly reported to a healthcare provider.

Q: Is Bicitra ever used for stomach acid issues?

Yes, in addition to its primary use as a systemic alkalizer, the official product information notes that Bicitra is also useful for quickly and effectively buffering and neutralizing stomach acid.

How to Store and Dispose of Bicitra?

The storage and disposal of Bicitra (Sodium Citrate and Citric Acid Solution) must strictly follow the conditions specified in the official labeling to maintain its stability.

Detail	Official Regulatory Requirement
Storage Temperature	Controlled Room Temperature, 20^circ to 25 C (68^circ to 77 F).
Prohibited Environments	Protect from freezing and avoid excessive heat.
Container Requirements	Keep the container tightly closed and preserved in a well-closed container; some formulations also require light-resistant containers.
Child Safety	Must be stored out of the sight and reach of children.
Disposal Instructions	Core labeling does not provide specific instructions for the household disposal of unused or expired product.